Cargando…

Low Concentrations of Metformin Selectively Inhibit CD133(+) Cell Proliferation in Pancreatic Cancer and Have Anticancer Action

Pancreatic cancer is the fourth leading cause of cancer related deaths in the United States. The prognosis remains dismal with little advance in treatment. Metformin is a drug widely used for the treatment of type II diabetes. Recent epidemiologic data revealed that oral administration of metformin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gou, Shanmiao, Cui, Pengfei, Li, Xiangsheng, Shi, Pengfei, Liu, Tao, Wang, Chunyou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648476/ https://www.ncbi.nlm.nih.gov/pubmed/23667692 http://dx.doi.org/10.1371/journal.pone.0063969

Ejemplares similares

Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133(+) Cell Populations and Suppressing ERK/P70S6K Signaling
por: Chai, Xinqun, et al.
Publicado: (2015)

Valproic acid sensitizes pancreatic cancer cells to natural killer cell-mediated lysis by upregulating MICA and MICB via the PI3K/Akt signaling pathway
por: Shi, Pengfei, et al.
Publicado: (2014)

The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis
por: Li, Xiaogang, et al.
Publicado: (2017)

Dendritic Cells Loaded with Pancreatic Cancer Stem Cells (CSCs) Lysates Induce Antitumor Immune Killing Effect In Vitro
por: Yin, Tao, et al.
Publicado: (2014)

MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3
por: Wang, Chunyou, et al.
Publicado: (2016)

The Reduction of Peripheral Blood CD4(+) T Cell Indicates Persistent Organ Failure in Acute Pancreatitis
por: Yang, Zhiyong, et al.
Publicado: (2015)

Cancer Stem-Like Cells Enriched in Panc-1 Spheres Possess Increased Migration Ability and Resistance to Gemcitabine
por: Yin, Tao, et al.
Publicado: (2011)

Use of probiotics in the treatment of severe acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials
por: Gou, Shanmiao, et al.
Publicado: (2014)

Assessment of the American Joint Commission on Cancer 8th Edition Staging System for Patients with Pancreatic Neuroendocrine Tumors: A Surveillance, Epidemiology, and End Results analysis
por: Li, Xiaogang, et al.
Publicado: (2018)

Prediction of Severe Acute Pancreatitis Using a Decision Tree Model Based on the Revised Atlanta Classification of Acute Pancreatitis
por: Yang, Zhiyong, et al.
Publicado: (2015)

MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway
por: Zhou, Wei, et al.
Publicado: (2015)

Oxytetracycline have the therapeutic efficiency in CD133(+) HCC population through suppression CD133 expression by decreasing of protein stability of CD133
por: Song, Yeonhwa, et al.
Publicado: (2018)

Effects of Metformin on CD133+ Colorectal Cancer Cells in Diabetic Patients
por: Zhang, Yanfei, et al.
Publicado: (2013)

Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells
por: Xue, Zhan-Xiong, et al.
Publicado: (2014)

Prospectively Isolated Cancer-Associated CD10(+) Fibroblasts Have Stronger Interactions with CD133(+) Colon Cancer Cells than with CD133(−) Cancer Cells
por: Cui, Lin, et al.
Publicado: (2010)

High Mobility Group Box Protein 1 Boosts Endothelial Albumin Transcytosis through the RAGE/Src/Caveolin-1 Pathway
por: Shang, Dan, et al.
Publicado: (2016)

The effect and molecular mechanism of hypoxia on proliferation and apoptosis of CD133(+) renal stem cells
por: Liu, Hong, et al.
Publicado: (2021)

Sulfasalazine attenuates evading anticancer response of CD133-positive hepatocellular carcinoma cells
por: Song, Yeonhwa, et al.
Publicado: (2017)

Circulating CD133+/–CD34– Have Increased c-MYC Expression in Myeloproliferative Neoplasms
por: Uslu Bıçak, İldeniz, et al.
Publicado: (2023)

The Effect of Metformin on the Proliferation, Apoptosis and CD133 mRNA Expression of Colon Cancer Stem Cells by Upregulation of miR 342-3p
por: Zhang, Yaqin, et al.
Publicado: (2021)

Minnelide effectively eliminates CD133(+) side population in pancreatic cancer
por: Nomura, Alice, et al.
Publicado: (2015)

Rapid Selection and Proliferation of CD133(+) Cells from Cancer Cell Lines: Chemotherapeutic Implications
por: Kelly, Sarah E., et al.
Publicado: (2010)

CD133, Selectively Targeting the Root of Cancer
por: Schmohl, Jörg U., et al.
Publicado: (2016)

Metformin Regulates the Expression of CD133 Through the AMPK-CEBPβ Pathway in Hepatocellular Carcinoma Cell Lines()
por: Maehara, Osamu, et al.
Publicado: (2019)

Role of CD133 in human embryonic stem cell proliferation and teratoma formation
por: Wang, Hua, et al.
Publicado: (2020)

Inverted U-Shaped Relationship between Central Venous Pressure and Intra-Abdominal Pressure in the Early Phase of Severe Acute Pancreatitis: A Retrospective Study
por: Yang, Chong, et al.
Publicado: (2015)

Active drain system with reticulated open-pore foam-surface dressing for postoperative pancreatic fistula in a rat model
por: Li, Yang, et al.
Publicado: (2021)

Expression of the "stem cell marker" CD133 in pancreas and pancreatic ductal adenocarcinomas
por: Immervoll, Heike, et al.
Publicado: (2008)

Epigenetic regulation of CD133 and tumorigenicity of CD133 positive and negative endometrial cancer cells
por: Friel, Anne M, et al.
Publicado: (2010)

Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations
por: Grasso, Carole, et al.
Publicado: (2016)

Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis
por: Durko, L., et al.
Publicado: (2017)

Liposarcoma cells with aldefluor and CD133 activity have a cancer stem cell potential
por: Stratford, Eva W, et al.
Publicado: (2011)

CD133-Positive Cells Might Be Responsible for Efficient Proliferation of Human Meningioma Cells
por: Tang, Hailiang, et al.
Publicado: (2012)

Tumor Cell Derived Exosomal GOT1 Suppresses Tumor Cell Ferroptosis to Accelerate Pancreatic Cancer Progression by Activating Nrf2/HO-1 Axis via Upregulating CCR2 Expression
por: Guo, Yao, et al.
Publicado: (2022)

CD45(dim)CD34(+)CD38(−)CD133(+) cells have the potential as leukemic stem cells in acute myeloid leukemia
por: Heo, Sook-Kyoung, et al.
Publicado: (2020)

CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines
por: Sana, Jiri, et al.
Publicado: (2011)

Corrigendum to “Expression and Clinical Significance of Cancer Stem Cell Markers CD24, CD44, and CD133 in Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis”
por: Durko, L., et al.
Publicado: (2017)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
por: Fritzenwanger, M, et al.
Publicado: (2009)

In triple negative breast tumor cells, PLC-β2 promotes the conversion of CD133(high) to CD133(low) phenotype and reduces the CD133-related invasiveness
por: Brugnoli, Federica, et al.
Publicado: (2013)

CD133 Role in Oral Carcinogenesis
por: Luna, Ealber Carvalho Macedo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m4dqb425ld98pslad3fr83bvn6